Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma

A 66-year old female with HIV-negative classic Kaposi's sarcoma responded to mTOR targeting by rapamycin. The response was well documented by PET-CT. This case provides supporting evidence that the mTOR pathway may be important in the tumorigenesis of KS and that rapamycin may have activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Merimsky, Ofer, Jiveliouk, Irina, Sagi-Eisenberg, Ronit
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391286/
https://www.ncbi.nlm.nih.gov/pubmed/18509482
http://dx.doi.org/10.1155/2008/825093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391286/
https://www.ncbi.nlm.nih.gov/pubmed/18509482
http://dx.doi.org/10.1155/2008/825093

Ejemplares similares